Latest Shareholder Approval News

Nufarm Limited posted a $165.3 million statutory loss for FY25, driven by significant restructuring charges and omega-3 price declines, while announcing a CEO transition effective January 2026.

LGI Limited reported robust FY25 results with a 14% rise in EBITDA and secured six new contracts, positioning the company for a 25-30% EBITDA increase in FY26. Key project completions and expansions underpin this momentum.

Ausgold Limited has raised A$80 million through a fully underwritten placement to fast-track the Katanning Gold Project, aiming for a final investment decision by mid-2026. The capital injection strengthens the company’s balance sheet and supports key development milestones.

Ridley Corporation reports solid FY25 earnings growth and outlines a diversified growth strategy for FY26, anchored by its recent Incitec Pivot Fertilisers acquisition.

Nufarm Limited has announced Rico Christensen as its new CEO, effective January 2026, succeeding Greg Hunt who will stay on as advisor until mid-2026. Christensen brings three decades of global agricultural sector expertise and a strong operational focus.

Nufarm Limited reported a $165.3 million statutory loss for FY25, driven by restructuring costs in Seed Technologies despite strong Crop Protection growth. A CEO transition and refinancing moves set the stage for FY26.

Helloworld Travel Limited has made a non-binding indicative all-cash offer to acquire the remaining shares of Webjet Group at A$0.90 per share, signaling a potential major consolidation in the online travel sector.

Decidr AI Industries has completed its acquisition of the remaining 49% stake in Decidr.ai, issuing 78.4 million shares to the vendor and appointing founder Paul Chan as co-CEO and Chief Innovation Officer.

Shriro Holdings Limited has announced a $5 million off-market share buy-back at $0.81 per share, representing nearly 8% of its issued capital and approved by shareholders. The move returns excess capital following a strategic shift and may reshape the company’s growth trajectory.

Andromeda Metals has raised nearly $1 million through a Share Purchase Plan, bringing total recent capital to almost $14 million to advance its Great White and HPA projects.

Infomedia Limited shareholders have overwhelmingly approved a scheme of arrangement for acquisition by a TPG Capital-managed entity, with final court approval scheduled for 21 November 2025. The deal will lead to Infomedia’s delisting from the ASX and includes a special dividend and tax ruling application.

Biotron Limited has launched a $1.5 million non-renounceable rights issue to fund its strategic acquisition of Sedarex Limited and support ongoing drug development programs. The capital raise follows shareholder approval and aims to diversify Biotron’s portfolio with a next-generation general anaesthetic.